Attention Deficit Disorder With Hyperactivity (ADHD)
0
Pipeline Programs
1
Companies
1
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Jerusalem PharmaceuticalsIsrael - Ramallah
1 programHealth promotion for mothers of children with ADHD in the ultra-orthodox communityN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2024
2025
2026
Jerusalem PharmaceuticalsHealth promotion for mothers of children with ADHD in the ultra-orthodox community
Clinical Trials (1)
Total enrollment: 32 patients across 1 trials
NCT06703242Jerusalem PharmaceuticalsHealth promotion for mothers of children with ADHD in the ultra-orthodox community
Pilot Study on a Health Promotion Intervention for Ultra-Orthodox Mothers of Children With ADHD
Start: Nov 2024Est. completion: May 202532 patients
N/ARecruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 32 patients
1 companies competing in this space